Using a reminder tool for diabetes kidney medicine after kidney injury
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether a reminder tool in the clinic helps doctors and pharmacists start a diabetes medicine (SGLT2 inhibitor) that may protect the kidneys after a kidney injury. Participation is limited to patients at specific clinics who have had a recent kidney injury and type 2 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at one of the participating clinics and have an appointment with a primary care doctor or clinic pharmacist.
- You have type 2 diabetes.
- You were hospitalized for acute kidney injury and discharged within the past year.
- You are between 30 and 75 years old.
- Your recent kidney function test (eGFR) is 30 or higher (after the injury).
- You are not pregnant, do not have a history of kidney transplant, and are not in hospice or receiving cancer care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different ways of reminding doctors about medicines that can help protect the kidneys in people with chronic kidney disease. If you join, your doctor may get extra information about treatments that could slow down kidney damage.
This study uses personalized risk information and digital tools to help people plan safe transitions after a recent hospital kidney injury. The goal is to better guide next steps and reduce the chance of future kidney problems.
This study tests whether a medicine called an SGLT2 inhibitor (which lowers blood sugar and helps the kidneys) can improve outcomes for people with acute heart failure and kidney problems. Participation involves taking the study drug or a placebo for a short time.
This study tests whether SGLT2 inhibitors (a type of diabetes drug that also helps kidneys) can help patients with acute kidney disease. It may be an option if you have diabetes or chronic kidney disease along with acute kidney problems.
This study tests a program to improve communication and care for people who leave the hospital with kidney injury that hasn't fully healed. It aims to help patients understand their condition and smoothly transition to follow-up care, which may improve recovery.
This study tests a decision-support tool to help emergency room doctors better detect and manage acute kidney injury (a sudden drop in kidney function). It may lead to earlier treatment and better outcomes for patients.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.